Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

Clinical trial NCT06293898 · RECRUITING

Trial details

NCT number: NCT06293898
Sponsor: SystImmune Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Endometrial Cancer Cervical Cancer Ovarian Cancer Urothelial Carcinoma Biliary Tract Cancer Breast Cancer Lung Cancer Gastric Cancer Gastroesophageal-junction Cancer Esophageal Cancer

Start date: 2024-02-09
Primary completion: 2028-12-15
Enrollment: 280

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.